🇺🇸 FDA
Patent

US 9918948

Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine

granted A61KA61K31/01A61K31/015

Quick answer

US patent 9918948 (Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine) held by TONIX PHARMA LIMITED expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TONIX PHARMA LIMITED
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/01, A61K31/015, A61K31/13, A61K31/131